Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-06

Clinical Trial Update: Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for opioid growth factor in patients with advanced, unresectable pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Opioid Growth Factor

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED